Cancer Research Annual Meeting 2010  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Published online first on March 17, 2009
[Cancer Research, 10.1158/0008-5472.CAN-08-3530]
This Article
Right arrow Full Text (Online First [PDF])
Right arrow Supplementary Data
Right arrow All Versions of this Article:
0008-5472.CAN-08-3530v1
69/7/3157    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimada, K.
Right arrow Articles by Konishi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimada, K.
Right arrow Articles by Konishi, N.

Molecular Biology, Pathobiology and Genetics

A Novel Human AlkB Homologue, ALKBH8, Contributes to Human Bladder Cancer Progression

Keiji Shimada 1, Mitsutoshi Nakamura 1, Satoshi Anai 2, Marco De Velasco 4, Motoyoshi Tanaka 4, Kazutake Tsujikawa 5, Yukiteru Ouji 3, and Noboru Konishi 1*

Departments of 1Pathology, 2Urology, and 3Parasitology, Nara Medical University School of Medicine, Shijo-cho, Kashihara, Nara; 4Department of Urology, Kinki University School of Medicine, Sayama, Osaka; and 5Department of Immunology, Osaka University, Graduate School and School of Pharmaceutical Sciences, Yamadaoka, Suita, Osaka, Japan

* To whom correspondence should be addressed. E-mail: nkonishi{at}naramed-u.ac.jp.


   Abstract

We recently identified a novel human AlkB homologue, ALKBH8, which is expressed in various types of human cancers including human urothelial carcinomas. In examining the role and function of ALKBH8 in human bladder cancer development in vitro, we found that silencing of ALKBH8 through small interfering RNA transfection reduced reactive oxygen species (ROS) production via down-regulation of NAD(P)H oxidase-1 (NOX-1) and induced apoptosis through subsequent activation of c-jun NH2-terminal kinase (JNK) and p38. However, we also found that JNK and p38 activation resulted in phosphorylation of H2AX ({gamma}H2AX), a variant of mammalian histone H2A, which contributes to the apoptosis induced by silencing ALKBH8 and NOX-1. Silencing of ALKBH8 significantly suppressed invasion, angiogenesis, and growth of bladder cancers in vivo as assessed both in the chorioallantoic membrane assay and in an orthotopic mouse model using green fluorescent protein–labeled KU7 human urothelial carcinoma cells. Immunohistochemical examination showed high expression of ALKBH8 and NOX-1 proteins in high-grade, superficially and deeply invasive carcinomas (pT1 and >pT2) as well as in carcinoma in situ, but not in low-grade and noninvasive phenotypes (pTa). These findings indicate an essential role for ALKBH8 in urothelial carcinoma cell survival mediated by NOX-1–dependent ROS signals, further suggesting new therapeutic strategies in human bladder cancer by inducing JNK/p38/{gamma}H2AX–mediated cell death by silencing of ALKBH8. [Cancer Res 2009;69(7):OF1–8]

Key Words: ALKBH8, NOX-1, reactive oxygen species, JNK, p38, {gamma}H2AX







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2009 by the American Association for Cancer Research.